Andrew S. Boyer, Executive Vice President at Amneal Pharmaceuticals, Inc. (AMRX), sold 58,604 shares at $4.13 ($242K) on 2023-08-11, disclosed to the SEC on 2023-08-15.
Open-market sale of $242k AMRX by Executive Vice President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.13 | 29,302 | $121K | 50.0% |
| 2 | $4.13 | 29,302 | $121K | 50.0% |
| Total | $4.13 avg | 58,604 | $242K | 100% |
| Filing → |
| AMRX | SELL | 2025-03-07 | $1.1M | — | Filing → |
| AMRX | SELL | 2024-08-16 | $983K | — | Filing → |
| AMRX | BUY | 2019-08-07 | $385K | — | Filing → |